Literature DB >> 11908248

Determining hyperforin and hypericin content in eight brands of St. John's wort.

Gerlie C de los Reyes1, Robert T Koda.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11908248     DOI: 10.1093/ajhp/59.6.545

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  13 in total

Review 1.  Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. Regulation and quality.

Authors:  Joanne Barnes
Journal:  Br J Clin Pharmacol       Date:  2003-03       Impact factor: 4.335

Review 2.  Pharmacovigilance of herbal medicines : a UK perspective.

Authors:  Joanne Barnes
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

3.  Drug-phytochemical interactions.

Authors:  Costas Ioannides
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

4.  The recovery time-course of CYP3A after induction by St John's wort administration.

Authors:  Hiromitsu Imai; Tsutomu Kotegawa; Kimiko Tsutsumi; Takuya Morimoto; Nobuoki Eshima; Shigeyuki Nakano; Kyoichi Ohashi
Journal:  Br J Clin Pharmacol       Date:  2008-02-20       Impact factor: 4.335

5.  The extent of induction of CYP3A by St. John's wort varies among products and is linked to hyperforin dose.

Authors:  Silke C Mueller; Jolanta Majcher-Peszynska; Bernhard Uehleke; Sebastian Klammt; Ralf G Mundkowski; Wolfram Miekisch; Hartwig Sievers; Steffen Bauer; Bruno Frank; Guenther Kundt; Bernd Drewelow
Journal:  Eur J Clin Pharmacol       Date:  2005-12-10       Impact factor: 2.953

6.  Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba.

Authors:  Bill J Gurley; Stephanie F Gardner; Martha A Hubbard; D Keith Williams; W Brooks Gentry; Yanyan Cui; Catharina Y W Ang
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

7.  No clinically relevant CYP3A induction after St. John's wort with low hyperforin content in healthy volunteers.

Authors:  Silke C Mueller; Jolanta Majcher-Peszynska; Ralf G Mundkowski; Bernhard Uehleke; Sebastian Klammt; Hartwig Sievers; Romanus Lehnfeld; Bruno Frank; Kerstin Thurow; Guenther Kundt; Bernd Drewelow
Journal:  Eur J Clin Pharmacol       Date:  2008-09-03       Impact factor: 2.953

8.  Effect of Asian ginseng, Siberian ginseng, and Indian ayurvedic medicine Ashwagandha on serum digoxin measurement by Digoxin III, a new digoxin immunoassay.

Authors:  Amitava Dasgupta; Gertie Tso; Alice Wells
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

9.  Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea.

Authors:  Bill J Gurley; Ashley Swain; Martha A Hubbard; D Keith Williams; Gary Barone; Faith Hartsfield; Yudong Tong; Danielle J Carrier; Shreekar Cheboyina; Sunil K Battu
Journal:  Mol Nutr Food Res       Date:  2008-07       Impact factor: 5.914

Review 10.  The natural treatment of hypertension.

Authors:  Amanda James Wilburn; Deborah S King; James Glisson; Robin W Rockhold; Marion R Wofford
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-05       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.